標題: Titlebook: Cystic Fibrosis in Primary Care; An Essential Guide t Douglas Lewis, MD, FAAFP Book 2020 Springer Nature Switzerland AG 2020 cystic fibrosi [打印本頁] 作者: 并排一起 時間: 2025-3-21 17:57
書目名稱Cystic Fibrosis in Primary Care影響因子(影響力)
書目名稱Cystic Fibrosis in Primary Care影響因子(影響力)學(xué)科排名
書目名稱Cystic Fibrosis in Primary Care網(wǎng)絡(luò)公開度
書目名稱Cystic Fibrosis in Primary Care網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Cystic Fibrosis in Primary Care被引頻次
書目名稱Cystic Fibrosis in Primary Care被引頻次學(xué)科排名
書目名稱Cystic Fibrosis in Primary Care年度引用
書目名稱Cystic Fibrosis in Primary Care年度引用學(xué)科排名
書目名稱Cystic Fibrosis in Primary Care讀者反饋
書目名稱Cystic Fibrosis in Primary Care讀者反饋學(xué)科排名
作者: archaeology 時間: 2025-3-21 20:19 作者: cumulative 時間: 2025-3-22 00:31 作者: 有特色 時間: 2025-3-22 08:35 作者: GLIB 時間: 2025-3-22 12:09
CF Airway Clearance,ly superior to another. Because of this, treatments are often individualized based on patient age, preference, and ease of use. ACTs serve either to increase laminar flow or to create shearing forces which help mechanically clear airway secretions and improve respiratory function.作者: 顧客 時間: 2025-3-22 13:00
CF Related Diabetes,omplications of CFRD include microvascular and macrovascular complications associated with more common forms of diabetes. With an overall knowledge of CFRD and the similarities and differences to more common forms of diabetes, CFRD can be easily managed in a primary care setting.作者: 顧客 時間: 2025-3-22 20:55
d to competently meet many of the care needs of those with cystic fibrosis...This book is edited by a family medicine physician who has specialist level experience with the disease. It opens with a background o978-3-030-25908-2978-3-030-25909-9作者: 共同生活 時間: 2025-3-22 21:59
Book 2020rrals and additional appointments. Family physicians are well-positioned and well-qualified to competently meet many of the care needs of those with cystic fibrosis...This book is edited by a family medicine physician who has specialist level experience with the disease. It opens with a background o作者: Aggrandize 時間: 2025-3-23 02:22 作者: Hiatal-Hernia 時間: 2025-3-23 05:33
CF Basics,), a protein on the cell surface which regulates chloride transport. The primary manifestations are lung disease leading to respiratory compromise and pancreatic insufficiency, resulting in failure to thrive. Diagnosis is made by sweat chloride testing in combination with genetic testing, and most n作者: RUPT 時間: 2025-3-23 10:00 作者: Gustatory 時間: 2025-3-23 17:03 作者: neoplasm 時間: 2025-3-23 18:17
Exercise for CF,ugh many studies. Not everyone uses the term exercise. Physical activity has been used in multiple studies as a synonymous term for exercise. For our chapter, we will be using the terms exercise and physical activity interchangeably. Exercise has been demonstrated to improve quality of life, disease作者: 吞下 時間: 2025-3-24 01:16
Inflammation in Cystic Fibrosis,sregulation of inflammatory mediators. The inflammatory component of cystic fibrosis begins early in life and is sustained and intense. This inflammation leads to airway damage in the form of bronchiectasis which is the main cause of morbidity and mortality for the cystic fibrosis patient. There are作者: Gentry 時間: 2025-3-24 04:57
CF Airway Clearance,lized recombinant human DNase (RhDNase, dornase alfa) is the most widely used mucolytic agent. It decreases sputum viscosity and should be considered in all CF patients ages 6 and older to help reduce pulmonary exacerbations (PEs) and improve lung function. Hypertonic saline, which serves to promote作者: 平 時間: 2025-3-24 10:07
Acute and Chronic Infection Management in CF,asis. All of these manifestations of cystic fibrosis contribute to a rich milieu for lower respiratory pathogens in patients affected by the disease. CF patients are, therefore, highly susceptible to chronic colonization with many pathogens such as . and .. They are also uniquely prone to acute infe作者: Nefarious 時間: 2025-3-24 12:02
Sexual and Reproductive Health and Counseling,n that patients desire to learn about the physiologic, genetic, and psychosocial aspects of SRH [1]. This chapter addresses pubertal development, family planning, and other SRH concerns, along with infertility, genetic screening, and pregnancy management.作者: 抱狗不敢前 時間: 2025-3-24 17:29
Gastrointestinal Disease and Nutrition in Cystic Fibrosis,f chloride. The mutation in this gene creates tenacious secretions in the lung, pancreas, intestinal tract, and hepatobiliary systems. The focus in this chapter will be pancreatic insufficiency, intestinal diseases, hepatobiliary disease, and nutritional factors (Sabharwal S, Schwarzenberg SJ. Cysti作者: Incumbent 時間: 2025-3-24 22:33 作者: Innovative 時間: 2025-3-25 00:28
Electrolyte Abnormalities in CF,ride. Appropriately evaluating patients is imperative to treatment and prevention of long-term sequelae. Once hyponatremia is diagnosed, volume status is assessed to determine etiology. Patients with acute hyponatremia and severe neurologic findings are admitted to the hospital and have rapid sodium作者: Hypopnea 時間: 2025-3-25 07:18
CFTR Carrier Status,ase states depending on the mutations at the cystic fibrosis transmembrane conductance regulator (CFTR) gene, modifier genes, environmental influences, and other factors. The CF carrier state is not necessarily asymptomatic or disease-free. Rather, CFTR-related disease (CFTR-RD) can affect the same 作者: atopic-rhinitis 時間: 2025-3-25 08:52 作者: 上釉彩 時間: 2025-3-25 14:11
Psychology and Psychotherapy in CF,re, diagnosed individuals are now living well into their 30s and 40s [1]. Like all chronic illnesses, CF poses unique challenges across the life cycle. This chapter is aimed at identifying how healthcare teams can provide family-oriented assessment and intervention targeted at increasing coping and 作者: 厚臉皮 時間: 2025-3-25 18:52
practitioner to help broaden their understanding of how the.Cystic fibrosis?is a disease that affects the entire body.?It tends to be thought of as primarily a pulmonary disease since pulmonary decline is the main factor in early mortality.?Because of the multi-system nature of the disease, a bette作者: 裂縫 時間: 2025-3-25 22:09 作者: Pelago 時間: 2025-3-26 03:50 作者: Classify 時間: 2025-3-26 05:47
Narjes Soleimanifar,Alireza Rezaiemanesh. This chapter is aimed at identifying how healthcare teams can provide family-oriented assessment and intervention targeted at increasing coping and resilience throughout the life cycle. To provide rich description, four case studies are highlighted.作者: 發(fā)源 時間: 2025-3-26 12:03 作者: 制度 時間: 2025-3-26 13:49 作者: Essential 時間: 2025-3-26 17:21
Inflammation in Cystic Fibrosis,ns and good mucus clearance also play a role. Both hypertonic saline treatment and exercise appear to help mitigate inflammation. Inflammation and its treatment are very active areas in cystic fibrosis research.作者: Hormones 時間: 2025-3-26 22:27
Electrolyte Abnormalities in CF,logic complication of overly rapid correction. Patients with cystic fibrosis are predisposed to hyponatremia due to increased sodium loss in sweat. Major electrolyte and volume changes can be prevented by proper instruction regarding fluid and sodium replacement during periods of exertion or prolonged heat exposure.作者: homocysteine 時間: 2025-3-27 02:12 作者: 喪失 時間: 2025-3-27 09:22 作者: 入伍儀式 時間: 2025-3-27 10:20
Psychology and Psychotherapy in CF,. This chapter is aimed at identifying how healthcare teams can provide family-oriented assessment and intervention targeted at increasing coping and resilience throughout the life cycle. To provide rich description, four case studies are highlighted.作者: ellagic-acid 時間: 2025-3-27 16:48 作者: Ornament 時間: 2025-3-27 21:44 作者: 淘氣 時間: 2025-3-28 01:26 作者: 易于 時間: 2025-3-28 04:34
?Mein Auto, mein Haus, meine Bank“egies for managing infectious complications of CF patients include chronic prophylactic antibiotics, use of systemic as well as inhaled antibiotics, mechanical assistance with mucus clearance, and scrupulous infection control measures.作者: 很像弓] 時間: 2025-3-28 07:15
Spondyloarthropathies and Food Intakeies have been developed and are currently available for about 50% of the CF population within the United States. Further therapeutics, including genetic therapy options, are in various stages of development with the eventual hope of providing CFTR modulating and/or genetic therapy options for all individuals with CF.作者: Subdue 時間: 2025-3-28 12:33
CFTR Physiology,rious organs including lungs, pancreas, intestines, hepatobiliary system, and the reproductive system (O’Sullivan and Freedman Lancet 373:1891–904, 2009). Lung disease is a major cause of mortality and morbidity in patients with CF.作者: 遺留之物 時間: 2025-3-28 15:58
Acute and Chronic Infection Management in CF,egies for managing infectious complications of CF patients include chronic prophylactic antibiotics, use of systemic as well as inhaled antibiotics, mechanical assistance with mucus clearance, and scrupulous infection control measures.作者: acrimony 時間: 2025-3-28 21:18
CFTR Corrector Therapies/New Therapies,ies have been developed and are currently available for about 50% of the CF population within the United States. Further therapeutics, including genetic therapy options, are in various stages of development with the eventual hope of providing CFTR modulating and/or genetic therapy options for all individuals with CF.作者: bisphosphonate 時間: 2025-3-29 02:41
Evolution of Cystic Fibrosis Care,ts is now multidisciplinary, yet must reflect the whole person rather than individual organ systems. The general pediatrician and the family physician have a role to play in the care of these patients because of the unique whole-person perspective practiced in these primary care disciplines.作者: flamboyant 時間: 2025-3-29 03:18
CF Basics,ew cases are now identified by newborn screening. New treatments have greatly increased the life expectancy of patients with the disease, and now more than half of the CF patients in the United States are adults. CFTR modulating medications are changing the trajectory of the disease, as they are highly effective at restoring CFTR function.作者: indifferent 時間: 2025-3-29 10:12 作者: 不能平靜 時間: 2025-3-29 13:54 作者: Sleep-Paralysis 時間: 2025-3-29 18:35
CFTR Carrier Status,ase states depending on the mutations at the cystic fibrosis transmembrane conductance regulator (CFTR) gene, modifier genes, environmental influences, and other factors. The CF carrier state is not necessarily asymptomatic or disease-free. Rather, CFTR-related disease (CFTR-RD) can affect the same organ systems involved in the CF patient.作者: deforestation 時間: 2025-3-29 23:44 作者: Osteons 時間: 2025-3-30 01:46
Spondyloarthropathies and Gut Microbiotaase states depending on the mutations at the cystic fibrosis transmembrane conductance regulator (CFTR) gene, modifier genes, environmental influences, and other factors. The CF carrier state is not necessarily asymptomatic or disease-free. Rather, CFTR-related disease (CFTR-RD) can affect the same organ systems involved in the CF patient.作者: 花束 時間: 2025-3-30 07:38 作者: 截斷 時間: 2025-3-30 11:15 作者: conference 時間: 2025-3-30 14:20
Clara Terzaghi,Cecilia Pasquali,Elia Paiusco long arm of chromosome 7 (Knowlton et al. Nature 318:380–2, 1985). This mutation can result in absent, abnormal, or reduced function of the CFTR protein which is a cAMP-regulated ion channel that controls transport of chloride, sodium, and bicarbonate across various cell membranes. Defective CFTR p作者: overbearing 時間: 2025-3-30 19:49 作者: Expiration 時間: 2025-3-30 23:14 作者: Compass 時間: 2025-3-31 03:25
Yoshiharu Shimozono,John G. Kennedysregulation of inflammatory mediators. The inflammatory component of cystic fibrosis begins early in life and is sustained and intense. This inflammation leads to airway damage in the form of bronchiectasis which is the main cause of morbidity and mortality for the cystic fibrosis patient. There are
